Insomnia – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Insomnia – Drugs In Development, 2024 report and make more profitable business decisions.
Insomnia is a sleep disorder that is characterized by difficulty falling and/or staying asleep. Symptoms include difficulty falling asleep at night, irritability, depression or anxiety, tension headaches, and distress in the stomach and intestines. Risk factors include age, mental health disorder, stress, and shift working.
The Insomnia drugs in development market research report provide comprehensive information on the therapeutics under development for Insomnia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Insomnia and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Insomnia | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 41 molecules, with 39 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Insomnia therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Insomnia pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Insomnia treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
3Z ehfAcahealth Pharma and Biotech Co Ltd
AfaSci Inc
Avecho Biotechnology Ltd
Bod Science Ltd
Cellix Bio Pvt Ltd
Cennerv Pharma (S) Pte Ltd
Closed Loop Medicine Ltd
Eisai Co Ltd
EUSOL Biotech Co Ltd
Guangdong East Sunshine Pharmaceutical Co Ltd
Guangzhou Liushun Biotechnology Co Ltd
Idorsia Pharmaceutical Ltd
Imbrium Therapeutics LP
Intra-Cellular Therapies Inc
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Johnson & Johnson
Linnet BioPharmaceuticals Inc
LP Pharmaceutical (Xiamen) Co Ltd
M et P Pharma AG
Medlab Clinical Ltd
NB Health Laboratory Co Ltd
Neurofix Pharma SA
NovaMedica
NW PharmaTech Ltd
Orion Corp
Overseas Pharmaceuticals Ltd
Reconnect Labs AG
Servatus Ltd
Shackelford Pharma Inc
Simcere Pharmaceutical Group Ltd
Sinsin Pharmaceutical Co Ltd
Taisho Pharmaceutical Holdings Co Ltd
Tetranov International Inc
Tritech Biopharmaceuticals Co Ltd
University of Pittsburgh
Vanda Pharmaceuticals Inc
Woolcock Institute of Medical Research
Yangtze River Pharmaceutical Group
Zelira Therapeutics Ltd
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Insomnia reports